| 0.649 0.009 (1.39%) | 05-23 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.85 |
1-year : | 0.93 |
| Resists | First : | 0.73 |
Second : | 0.8 |
| Pivot price | 0.72 |
|||
| Supports | First : | 0.62 |
Second : | 0.51 |
| MAs | MA(5) : | 0.67 |
MA(20) : | 0.72 |
| MA(100) : | 0.75 |
MA(250) : | 0.83 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 9  |
D(3) : | 12.4 |
| RSI | RSI(14): 35.1 |
|||
| 52-week | High : | 1.22 | Low : | 0.56 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RVP ] has closed above bottom band by 8.2%. Bollinger Bands are 71.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.66 - 0.66 | 0.66 - 0.66 |
| Low: | 0.61 - 0.62 | 0.62 - 0.62 |
| Close: | 0.64 - 0.65 | 0.65 - 0.65 |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Thu, 15 May 2025
Retractable Technologies, Inc. Results for the Period Ended March 31, 2025 - Business Wire
Thu, 15 May 2025
Retractable Technologies: Q1 Earnings Snapshot - San Francisco Chronicle
Thu, 15 May 2025
Retractable Technologies: Q1 Earnings Snapshot - marketscreener.com
Wed, 14 May 2025
Retractable Technologies CEO Thomas Shaw acquires $16,492 in stock - Investing.com
Mon, 12 May 2025
Retractable Technologies CEO Thomas Shaw buys $2,245 in stock By Investing.com - Investing.com Nigeria
Mon, 12 May 2025
Retractable Technologies CEO Thomas Shaw buys $2,245 in stock - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 30 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 56.8 (%) |
| Held by Institutions | 7.5 (%) |
| Shares Short | 38 (K) |
| Shares Short P.Month | 35 (K) |
| EPS | -0.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.84 |
| Profit Margin | -46.8 % |
| Operating Margin | -95.6 % |
| Return on Assets (ttm) | -4.5 % |
| Return on Equity (ttm) | -19 % |
| Qtrly Rev. Growth | -24.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.27 |
| EBITDA (p.s.) | -0.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | -1.09 |
| PEG Ratio | 0 |
| Price to Book value | 0.22 |
| Price to Sales | 0.5 |
| Price to Cash Flow | 3.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|